|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Mineralys Therapeutics, Inc. (MLYS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
40,860,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
555,555 |
559,805 |
566,305 |
3,322,555 |
| Total Buy Value |
$7,499,993 |
$7,525,349 |
$7,605,534 |
$51,705,534 |
| Total People Bought |
1 |
2 |
2 |
6 |
| Total Buy Transactions |
1 |
2 |
5 |
10 |
| Total Shares Sold |
0 |
0 |
231,716 |
231,716 |
| Total Sell Value |
$0 |
$0 |
$2,994,401 |
$2,994,401 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-04-12 |
4 |
OE |
$1.08 |
$6,857 |
D/D |
6,349 |
66,997 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-04-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
60,648 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-03-12 |
4 |
OE |
$1.08 |
$6,856 |
D/D |
6,348 |
55,631 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-03-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
49,283 |
|
- |
|
| Shah Rajeev M. |
Director |
– • – |
2024-02-12 |
4 |
A |
$13.50 |
$22,578,858 |
I/I |
1,672,508 |
2,983,755 |
|
- |
|
| Akkaraju Srinivas |
|
– • • |
2024-02-12 |
4 |
A |
$13.50 |
$7,499,993 |
I/I |
555,555 |
5,074,916 |
|
- |
|
| Samsara Biocapital, L.p. |
10% Owner |
– – • |
2024-02-12 |
4 |
B |
$13.50 |
$7,499,993 |
I/I |
555,555 |
5,074,916 |
1.5 |
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-02-12 |
4 |
OE |
$0.54 |
$9,566 |
D/D |
11,366 |
44,266 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-01-12 |
4 |
OE |
$1.08 |
$6,856 |
D/D |
6,348 |
32,900 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-01-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
26,552 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2023-12-11 |
4 |
OE |
$0.54 |
$2,710 |
D/D |
5,018 |
20,069 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2023-11-22 |
4 |
B |
$5.97 |
$25,356 |
D/D |
4,250 |
1,049,068 |
2.81 |
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2023-11-13 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
15,051 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2023-11-03 |
4 |
OE |
$0.54 |
$5,418 |
D/D |
10,034 |
10,034 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2023-09-06 |
4 |
B |
$12.08 |
$27,180 |
D/D |
2,250 |
1,044,818 |
2.81 |
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2023-08-17 |
4 |
B |
$12.10 |
$27,225 |
D/D |
2,250 |
1,042,568 |
2.81 |
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2023-08-11 |
4 |
B |
$12.89 |
$25,780 |
D/D |
2,000 |
1,040,318 |
2.81 |
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2023-08-11 |
4 |
S |
$12.81 |
$2,012,336 |
D/D |
(157,091) |
0 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2023-08-11 |
4 |
OE |
$0.54 |
$125,967 |
D/D |
157,091 |
76,182 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2023-08-10 |
4 |
S |
$13.16 |
$982,065 |
D/D |
(74,625) |
0 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2023-08-10 |
4 |
OE |
$0.54 |
$40,298 |
D/D |
74,625 |
74,625 |
|
- |
|
| Hbm Bioventures Cayman Ltd |
10% Owner |
– – • |
2023-02-14 |
4 |
B |
$16.00 |
$5,000,000 |
D/D |
312,500 |
3,218,106 |
2.45 |
- |
|
| Hbm Bioventures Cayman Ltd |
10% Owner |
– – • |
2023-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,905,606 |
2,905,606 |
|
- |
|
| Catalys Pacific Fund, Lp |
10% Owner |
– – • |
2023-02-14 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
9,194,579 |
1.5 |
- |
|
| Catalys Pacific Fund, Lp |
10% Owner |
– – • |
2023-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
4,314,093 |
8,944,579 |
|
- |
|
33 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
